Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bankruptcy court smiles on Substance Abuse deal:

This article was originally published in Clinica

Executive Summary

Plans by Substance Abuse Technologies to refinance itself have met with the approval of the bankruptcy court in Florida which is overseeing SAT's Chapter 11. Under the plan the company gains a private investment of a $3 million line of credit to fund day-to-day needs and to complete the purchase of DataMed International. SAT is now developing a reorganisation plan to put before the court. The company says that it will emerge from Chapter 11 stronger, with less debt and a greater market share.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel